Please login to the form below

Not currently logged in
Email:
Password:

Marc Becker joins CRISPR Therapeutics

He becomes chief financial officer

CRISPR Therapeutics Marc BeckerCRISPR Therapeutics has appointed Marc Becker as its new chief financial officer with remit to drive development of its gene-editing technology platform.

Becker brings over 20 years of commercial, operational and corporate finance expertise to the role, having held senior positions at BankBoston, Genzyme, KPMG and rEVO Biologics.

He joins the Switzerland-headquartered biopharmaceutical company from rEVO Biologics, where he served as its chief financial officer from 2012 until February this year.

While at rEVO, Becker was responsible for leading the finance department, directing the firm's market strategy and managing its governance.

Rodger Novak, chief executive officer of CRISPR Therapeutics, said: “Marc's extensive network and proven track record to establish internal controls will be vital as we continue to engage in key strategic ventures to support the discovery, development and commercialisation of new breakthrough therapeutics.”

Becker said: “I am excited to join the CRISPR Therapeutics leadership team as the company's growth accelerates with the introduction of strategic partnerships and ventures.

“Our technology is truly revolutionary and I'm delighted to be part of the team that will enable the development of life-changing medicines.”

21st March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics